Bilypsa

Bilypsa is used to lower cholesterol levels and triglycerides in patients suffering from type 2 diabetes mellitus. It has the active ingredient of Saroglitazar which is a dual peroxisome proliferator-activated receptor (PPAR) inhibitor that is used to treat high cholesterol in people with diabetic dyslipidemia. It aids in the management of high cholesterol, especially triglycerides,